Kyntra Bio, Inc. (LON:0IL8)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Novel Therapeutics	29.62M
Novel Therapeutics Growth	-79.95%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States	26.11M
United States Growth	101.48%
Europe	6.27M
Europe Growth	-34.34%
China	91.00K
China Growth	-99.92%
Japan	-2.85M
Japan Growth	-117.99%